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Abstract: Cardiometabolic disorders are among the leading causes of mortality in the human pop-
ulation. Dietary polyphenols exert beneficial effects on cardiometabolic health in humans. Molecu-
lar mechanisms, however, are not completely understood. Aiming to conduct in-depth integrative 
bioinformatic analyses to elucidate molecular mechanisms underlying the protective effects of pol-
yphenols on cardiometabolic health, we first conducted a systematic literature search to identify 
human intervention studies with polyphenols that demonstrate improvement of cardiometabolic 
risk factors in parallel with significant nutrigenomic effects. Applying the predefined inclusion cri-
teria, we identified 58 differentially expressed genes at mRNA level and 5 miRNAs, analyzed in 
peripheral blood cells with RT-PCR methods. Subsequent integrative bioinformatic analyses 
demonstrated that polyphenols modulate genes that are mainly involved in the processes such as 
inflammation, lipid metabolism, and endothelial function. We also identified 37 transcription fac-
tors that are involved in the regulation of polyphenol modulated genes, including RELA/NFKB1, 
STAT1, JUN, or SIRT1. Integrative bioinformatic analysis of mRNA and miRNA-target pathways 
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demonstrated several common enriched pathways that include MAPK signaling pathway, TNF sig-
naling pathway, PI3K-Akt signaling pathway, focal adhesion, or PPAR signaling pathway. These 
bioinformatic analyses represent a valuable source of information for the identification of molecular 
mechanisms underlying the beneficial health effects of polyphenols and potential target genes for 
future nutrigenetic studies. 
Keywords: systematic literature search; nutrigenomics; integrative bioinformatics; polyphenols; 
cardiometabolic health; human 
 
1. Introduction 
Polyphenols are plant secondary metabolites with important physiological functions 
[1,2] and their production is increased as a response to external stressors, such as drought, 
cold, heat, UV irradiation, to cite only a few [3]. More than 8000 different polyphenols 
have been described in planta [4], but only about 500 are relevant for human nutrition [5]. 
Dietary polyphenols are divided into flavonoids and non-flavonoids. The subclass of fla-
vonoids is further subdivided into flavanols, flavonols, flavones, isoflavones, flavanones, 
and anthocyanins. Nutritionally relevant non-flavonoids include phenolic acids, hy-
droxycinnamates, stilbenes, and lignans [1]. It is estimated that the usual human diet pro-
vides an average daily intake of approximately 1 g of total polyphenols [6]. However, 
there is a high variation in the daily intake of polyphenols, as it can range from less than 
500 [7] to more than 1500 mg/day [8], which reflects the differences in nutritional habits 
between individuals, but also at the population level. 
Epidemiological studies have reported positive effects of polyphenol intake on car-
diometabolic health in humans [9,10]. These data initiated numerous human intervention 
trials to study the effects of various dietary polyphenols on cardiometabolic risk factors in 
subjects of different gender, age, or health status. Interventions included pure compounds 
and plant extracts along with various polyphenol-rich foods or beverages. Given the di-
versity in study populations, along with food bioactives and food matrices, the variability 
observed in the different outcomes is not surprising. The vast majority of studies report 
beneficial effects of polyphenols on cardiometabolic risk factors. For example, it has been 
demonstrated that cocoa polyphenols improve endothelial function in patients with non-
alcoholic steatohepatitis [11]. In hypertensive patients with impaired glucose tolerance, 
cocoa polyphenols improved endothelial function and insulin sensitivity and decreased 
systolic and diastolic blood pressure [12]. A positive effect on blood pressure has also been 
reported with grape seed extract treatment in subjects with pre-hypertension [13]. In ad-
dition, grape polyphenols prevented fructose-induced oxidative stress and insulin re-
sistance in overweight or obese first-degree relatives of patients with type 2 diabetes [14]. 
Extra virgin olive oil polyphenols also have been suggested to have a positive effect on 
cardiometabolic health in humans [15,16]. Furthermore, several studies have revealed 
within-group variability in response to the intake of these plant food bioactives [17,18]. 
Analyses of interindividual variability in response to dietary polyphenols identified po-
tential main factors involved, such as gender, age, ethnicity, disease, and metabolic state, 
gut microbiota, and gene polymorphisms [19,20]. 
Although there are a lot of studies pointing to the direction of beneficial effects of 
polyphenols on cardiometabolic health in humans, as yet no clear molecular mechanisms 
have been clearly highlighted. Several studies have shown that diets, foods, and drinks 
(such as Mediterranean diet or low-dose alcohol consumption) can exert important nutri-
genomic modifications which present important molecular mechanisms underlying their 
health properties [21,22]. Notwithstanding, experimental evidence indicates that many of 
the biological effects of polyphenols are mediated through nutri(epi)genomic mechanisms 
involving interactions with cell signaling proteins and transcription factors (TFs) [23]. For 
example, anthocyanins and their metabolites possess the capacity to bind with signaling 
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proteins that are involved in monocyte adhesion and trans-endothelial migration, pro-
cesses that are attenuated in vitro following pretreatment of endothelial cells with these 
bioactive compounds and their circulating metabolites [24]. Furthermore, integrative sys-
tematic bioinformatic analyses in cell models relevant for cardiometabolic disease, which 
include adipocytes, hepatocytes, endothelial, smooth muscle, and immune cells, demon-
strated that flavanols and their metabolites modulate the expression of genes that are pre-
dominantly involved in inflammation, leukocyte adhesion and trans-endothelial migra-
tion, and lipid metabolism [25]. Polyphenols may modulate the expression/activity of the 
enzymes of arachidonic acid cascade and consequently the biosynthesis of eicosanoids, 
thereby controlling the inflammatory processes involved in cardiovascular diseases [26]. 
Polyphenols can also interact with specific receptors, such as type 2 taste receptors, which 
are responsible for the detection of bitter taste. These receptors have also been discovered 
in several extra-oral tissues, including human intestine where they have been associated 
with nutrient-gut interactions that influence gastrointestinal motility, appetite, and glyce-
mia [27]. 
It is particularly difficult to investigate molecular mechanisms underlying positive 
cardiometabolic effects of polyphenols in humans, and therefore, the number of such 
studies is limited. Recruitment of participants with similar baseline characteristics, com-
pliance with the intervention and participants’ follow-up in long-term studies, are all very 
challenging. Availability of samples for analyses is another limiting factor in human in-
tervention studies, most of them being conducted using blood samples for analysis of gene 
expression, and only a small number of studies included skeletal muscle or adipose tissue 
[28,29]. Although numerous human intervention studies analyzed the effects of polyphe-
nols on cardiometabolic risks, such as blood lipids, blood pressure, blood glucose, insulin 
resistance, endothelial function, oxidative stress, etc., many have not assessed the effects 
on gene expression. Another challenge in studying the molecular mechanisms of poly-
phenols’ health properties is the use of different methodological approaches in investigat-
ing the gene expression. For example, apart from the classical methodology of analyzing 
gene expression of several target RNAs with RT-PCR methods, innovative -omics tech-
nologies allow analysis of gene expression of hundreds or thousands of genes at the same 
time. In terms of the quantity of obtained data, the advantage of the -omics technologies 
is undoubtable. However, the fact that verification with classical methods does not always 
corroborate with the obtained results [30,31], imposes the need for separate analyses and 
interpretation of data from studies that had adopted different methodological approaches. 
Therefore, we conducted a systematic literature search aiming to identify human in-
tervention studies with polyphenols that demonstrated significant modulation in gene 
expression in parallel with positive effect/s on cardiometabolic risk factors. In our study, 
we focused only on studies that adopted a targeted approach, i.e., analyzed changes in 
the expression of several target mRNAs or miRNAs with RT-PCR methods. We then ap-
plied integrative bioinformatic analyses of identified nutrigenomic effects, to gain a better 
understanding of the overall molecular mechanisms of polyphenols in humans underly-
ing their health properties. 
2. Materials and Methods 
2.1. Strategy for Literature search and Data Extraction 
All literature relevant to the effect of polyphenols on gene expression and cardiomet-
abolic endpoints in human trials was searched and obtained using the Preferred Report-
ing Items for Systematic Reviews (PRISMA) statement guidelines with a predetermined 
search strategy [32]. A comprehensive search on PubMed and Web of Science, using Med-
ical Subject Headings (MeSH) and Boolean operators where appropriate, was conducted 
in July 2018, with an update in November 2019. The search included keywords referring 
to bioactives (polyphenols, flavonoids, flavanols, flavanones, epicatechin, catechin, pro-
cyanidin, anthocyanins, resveratrol, hydroxytyrosol, extracts, fruits, juice, grapes, citrus, 
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pomegranate, apple, tea, coffee, cocoa, olive oil, chocolate, berries, isoflavones, daidzein, 
equol, hesperetin), type of studies (human, clinical trials, randomized, patients, volun-
teers, males, females), nutrigenomic analysis (nutrigenomic, genomic, genome, gene, gene 
expression, transcription, mRNA, messenger RNA, RT-PCR, PCR-arrays, microarrays, 
macroarrays, epigenome, miRNA, ncRNA), and target tissues (peripheral blood mononu-
clear cells, T-cells, B-cells, lymphocytes, monocytes, blood, blood cells, platelets, adipose 
tissue, adipocytes, liver, plasma, serum). Following the identification of the publications 
using the aforementioned terms, the search results were narrowed down by only selecting 
studies with a targeted approach published in English language. 
Inclusion criteria for data extraction were as follows: human intervention studies of 
cardiometabolic disease or cardiometabolic risk factors where polyphenols were used for 
intervention, and modulation of gene expression was studied at mRNA and/or miRNA 
level, which was analyzed with RT-PCR methods. Furthermore, in order to be included 
in our analysis, the publications should have reported at least one beneficial cardiometa-
bolic outcome, such as: improved plasma lipid status (total cholesterol, triglycerides, 
HDL-cholesterol, LDL-cholesterol, apoA1, apoB, or oxLDL, etc.), improved oral glucose 
tolerance test, decreased fasting glucose, glycated hemoglobin, insulin resistance, blood 
pressure, body weight, waist circumference, systemic inflammation (circulating CRP, 
TNFα, interleukins, etc.), or decreased oxidative stress. Studies reporting an unfavorable 
cardiometabolic outcome, for example, increased LDL-cholesterol, were excluded from 
our analysis. In addition, studies that did not include a control of polyphenol intervention, 
or studies of co-interventions (for example, co-interventions of polyphenols with vitamins 
or exercise), were also excluded. 
A template for data extraction was designed specifically for this study. The template 
was pilot tested to verify the accuracy of the data extraction. The final version of the tem-
plate was distributed among the participants. Extracted data include: details about the 
paper (PMID, authors, year of publication, title), information about the study population 
(gender, age, number of participants, health status), information about the intervention 
(bioactive/s, dose and duration of intervention), study design, information about the car-
diometabolic outcomes (including both studied and significantly modulated), and infor-
mation about gene expression (mRNA and/or miRNA, analytical method, tissue/cells an-
alyzed for gene expression, gene symbol as reported in the paper, official gene symbol, 
and official gene name). Only genes that were significantly modulated by the intervention 
(p < 0.05) were extracted from the eligible papers, and subsequently subjected to bioinfor-
matic analyses. Extracted data were cross-checked by two participants. In case of doubts 
or disagreement, a third participant was consulted. 
2.2. Bioinformatic Analyses 
Pathways enrichment analyses were conducted using GeneTrail2 (https://gen-
etrail2.bioinf.uni-sb.de/, accessed on 24 January 2020) [33], version 1.6, as a platform to 
access KEGG and BioCarta databases, using the following settings: over-representation 
analysis; null hypothesis (for p-value computation)—two-sided; method to adjust p-val-
ues—Benjamini-Yekutieli; significance level—0.05. All supported genes in the NCBI da-
tabase were taken as a reference. 
Interactions between functional groups of genes were analyzed with Cytoscape soft-
ware (version 3.7.2; https://cytoscape.org/, accessed on 1 June 2020) [34], using the appli-
cation ClueGO [35], connected to CluePedia [36]. 
Protein-protein interactions (PPIs) were analyzed using the database STRING 
(https://string-db.org/, accessed on 25 January 2020) [37], version 11.0, applying the fol-
lowing settings: confidence; text-mining, experiments, databases, co-expression; high con-
fidence—0.700; no more than 10 interactions in the first shell and no more than 5 interac-
tions in the second shell. The obtained protein network was organized in three clusters of 
functionally interconnected proteins. 
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Transcription factors that regulate the expression of polyphenol modulated genes 
were identified using Enrichr (https://amp.pharm.mssm.edu/Enrichr/, accessed on 25 Jan-
uary 2020) [38,39], as a platform to access the database TRRUST Transcription Factors 2019 
[40]. Interactions between the transcription factors and the genes they regulate were vis-
ualized with Cytoscape software (version 3.7.1; https://cytoscape.org/, accessed on 1 June 
2020) [41]. 
To identify mRNAs regulated by polyphenol modulated miRNAs, i.e., predicted 
miRNA targets, we used miRBase (http://www.mirbase.org/, accessed on 8 February 
2020) [42], as a platform to access the following databases: TargetMiner, TargetScanVert 
and miRDB. For ID conversion of genes that were retrieved with the database Tar-
getMiner, we used the ID convert tool of the database SYNGO (https://syngoportal.org/, 
accessed on 8 February 2020) [43]. InteractiVenn (http://www.interactivenn.net/, accessed 
on 8 February 2020) [44] was used as a tool to retrieve the predicted miRNA targets that 
are in common for the selected databases, which were subsequently used for pathways 
enrichment and integration analyses. Interactions between miRNA targets were visual-
ized with Cytoscape software (version 3.7.1; https://cytoscape.org/, accessed on 1 June 
2020) [41]. To compare the mRNAs extracted from the literature to the miRNA targets, 
and to analyze (a) the genes in common and (b) the genes that belong to the same enriched 
(ontology) term, we used the bioinformatic tool Metascape (http://metascape.org, ac-
cessed on 3 April 2020; the option “Multiple Gene List”) [45], where the results are visu-
alized with Circos plot (http://circos.ca/, accessed on 3 April 2020) [46]. Enriched terms for 
both gene sets are visualized using a heatmap plot. 
To compare KEGG pathways associated with mRNAs extracted from the literature 
and predicted miRNA targets, the enriched pathways obtained in our previous steps were 
used to build a network of pathways; two pathways were considered interconnected 
where at least one of the mRNAs or miRNA targets involved in them are common to both. 
Networks were constructed and visualized using Cytoscape software (version 3.7.1; 
https://cytoscape.org/, accessed on 1 June 2020) [41]. Data preparation was performed 
with the use of several R packages, including splitstackshape (https://github.com/mrd-
wab/splitstackshape, accessed on 16 June 2020), data.table 
(https://github.com/Rdatatable/data.table, accessed on 16 June 2020), dplyr (http://dplyr.ti-
dyverse.org, accessed on 16 June 2020; https://github.com/tidyverse/dplyr, accessed on 16 
June 2020), and string (http://stringr.tidyverse.org, accessed on 16 June 2020; 
https://github.com/tidyverse/stringr, accessed on 16 June 2020). Pathway networks were 
built separately for pathways enriched in each category and pathways considering all cat-
egories’ components together in a global pathway enrichment analysis. To obtain the 
pathways with the highest degree (number of connections of one node to other nodes), 
the Cytoscape Network Analyzer application was used (http://apps.cyto-
scape.org/apps/networkanalyzer, accessed on 16 June 2020). 
For integrative analysis of extracted mRNAs, their associated TFs, and extracted miR-
NAs, we used the 3D-layer option in the bioinformatic tool OmicsNet (https://www.om-
icsnet.ca/, accessed on 10 February 2020) [47,48]. Official gene names and symbols were 
identified using GeneCards (https://www.genecards.org/, accessed on 22 May 2020) [49]. 
Where applicable, protein names were searched in the UniProt database (https://www.uni-
prot.org/, accessed on 22 May 2020) [50]. 
  




3.1. Studies, Bioactives and Differentially Expressed Genes 
A comprehensive search on PubMed and Web of Science, conducted in July 2018, 
with an update in November 2019, resulted in 8678 documents. After removal of dupli-
cates, and using “Human” and “RCT” and “Clinical study” and “Clinical trial” and “Con-
trolled Clinical Trial” and “Multicenter Study” filters, this number dropped to 465 manu-
scripts, which were further screened for eligibility. Based on titles and abstracts, 89 papers 
were selected for data extraction and distributed among the participants (Figure 1). After 
detailed analysis of the full text, and applying the predefined inclusion/exclusion criteria, 
we identified seven papers that report significant changes in gene expression accompa-
nied with at least one favorable cardiometabolic outcome in controlled human interven-
tion studies with polyphenols [51–57]. For one of the studies [57], information about the 
study design and cardiometabolic outcomes was extracted from a previously published 
paper [58]. 
 
Figure 1. Flowchart of the literature search and data extraction. 
All studies used peripheral blood mononuclear cells (PBMCs), except one in which 
white blood cells were used, as biological material for analysis of modulations in gene 
expression (Table 1). Polyphenols from different origins, including olive oil and grape ex-
tracts, as well as pure compounds such as resveratrol, quercetin, or curcumin were used 
in the nutrigenomic studies. Doses varied in a wide range, as did the duration of interven-
tions, which ranged from 2 or 5 h (acute studies) up to one year (chronic studies). Study 
populations included adults (men, women or both) of various age groups, up to 80 years 
old. There was also a large variability in the health status of study populations, ranging 
from healthy subjects with cardiometabolic risk factors, to patients with a diagnosed car-
diometabolic disease (Table 1). As for the modulation of gene expression, we identified 58 
differentially expressed genes at mRNA level (one duplicate was removed), and 5 differ-
entially expressed miRNAs (Table 1), which were subjected to bioinformatic analyses. 
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Table 1. Human intervention studies on nutrigenomic effects of polyphenols, associated with positive cardiometabolic outcomes. 
Intervention Participants 
Study Design and Outcomes Related to Cardiometa-
bolic Health 
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3.2. mRNAs—Bioinformatic Analyses 
3.2.1. Pathways Analyses 
To better understand the biological meaning of genes extracted from the literature, 
we first conducted bioinformatic analyses to identify pathways significantly associated 
with polyphenol modulated genes. Using GeneTrail2 as a platform to access KEGG and 
BioCarta databases, we identified N = 71 KEGG and N = 42 BioCarta pathways that are 
significantly associated with extracted genes, modulated at the mRNA level. Among 
KEGG pathways retrieved with this analysis, N = 32 pathways are related to cellular pro-
cesses, whereas the others are related to various diseases. Among the top 25 BioCarta 
pathways, N = 24 are related to cellular processes. A deeper insight into KEGG and Bio-
Carta pathways related to cellular processes demonstrated that these pathways are mainly 
involved in endothelial function, cell signaling, inflammation, and lipid metabolism, as 
depicted in Figure 2. The most enriched pathways include: cytokine-cytokine receptor in-
teraction, encompassing N = 23 differentially expressed genes at mRNA level, i.e., hits, 
(CCL20, CCL22, CCL3, CCR1, CCR5, CCR7, CD40, CD40LG, CX3CR1, CXCL10, CXCL16, 
CXCL6, CXCL9, CXCR1, CXCR2, CXCR3, CXCR6, IL1B, IL1R2, IL23A, IL6, IL7R, TNF); 
chemokine signaling pathway (with N = 18 hits: CCL20, CCL22, CCL3, CCR1, CCR5, CCR7, 
CX3CR1, CXCL10, CXCL16, CXCL6, CXCL9, CXCR1, CXCR2, CXCR3, CXCR6, NFKBIA, 
RAC1, STAT1); cell adhesion molecules (N = 6 hits: CD40, CD40LG, ICAM2, ICAM3, 
ITGB2, PECAM1); toll-like receptor signaling pathway (N = 10 hits: CCL3, CD40, CXCL10, 
CXCL9, IL1B, IL6, NFKBIA, RAC1, STAT1, TNF); adipocytokine signaling pathway (N = 6 
hits: ADIPOR1, ADIPOR2, CD36, NFKBIA, PPARA, TNF); TNF signaling pathway (N = 6 
hits: CCL20, CXCL10, IL1B, IL6, NFKBIA, TNF); PPAR signaling pathway (N = 5 hits: CD36, 
OLR1, PPARA, PPARD, PPARG); NF-kappa B signaling pathway (N = 5 hits: CD40, 
CD40LG, IL1B, NFKBIA, TNF); PI3K-Akt signaling pathway (N = 5 hits: IL6, IL7R, ITGA5, 
ITGB3, RAC1); nuclear receptors in lipid metabolism and toxicity (N = 7 hits: ABCA1, 
ABCB4, ABCC2, ABCG1, PPARA, PPARD, PPARG); ABC transporters (N = 6 hits: ABCA1, 
ABCA2, ABCA4, ABCB4, ABCC2, ABCG1); hematopoietic cell lineage (N = 8 hits: CD36, 
IL1B, IL1R2, IL6, IL7R, ITGA5, ITGB3, TNF); selective expression of chemokine receptors 
during T-cell polarization (N = 6 hits: CCL3, CCR1, CCR5, CCR7, CD40LG, CXCR3). 
3.2.2. Interactions between Functional Groups of Genes 
Analysis of interactions between functional groups of differentially expressed 
genes was conducted using the applications ClueGO and CluePedia in Cytoscape soft-
ware, calculating not only the interactions between polyphenol-affected pathways, but 
also the role and involvement of modulated genes within the network. Similar to path-
ways enrichment analyses, disease-related pathways were excluded from the graphical 
presentation (Figure 3). Analysis of interactions between functional groups of genes con-
firms the predominant effects of polyphenols on pathways involved in cell signaling re-
lated to inflammation, endothelial dysfunction, and lipid metabolism. In addition, this 
analysis demonstrates that TNF and NFKBIA are shared among at least three of the iden-
tified clusters of pathways, depicted in different colors in Figure 3. As such, these genes are 
likely to play a central role in cardiometabolic health-promoting effects of polyphenols. 
 




Figure 2. KEGG and top BioCarta pathways related to cellular processes, significantly associated with polyphenol modulated mRNA transcripts (x-axis represents the number of hits, 
i.e., number of genes in the pathway that are extracted from the eligible papers; within each group, pathways are arranged according to their p-values, in ascending order). KEGG 
pathways are marked with *; BioCarta pathways are marked with **. 




Figure 3. Interactions between functional groups of genes modulated by polyphenols. 
3.2.3. Protein-Protein Interactions 
Furthermore, we performed protein-protein interactions analysis for proteins en-
coded by polyphenol modulated mRNA transcripts, using the bioinformatic tool STRING. 
This analysis also revealed N = 15 neighboring proteins, ten of which were within the first 
shell of interactions, and five within the second shell. We also used the functionality of 
STRING for the organization of proteins in functionally differentiated clusters, which al-
lows better interpretation of extracted data. For our set of differentially expressed genes, 
three well-defined protein clusters are clearly distinctive (Figure 4A), mainly involved in 
inflammation (blue color), PPAR signaling (green color), and chemokine signaling (most 
of the proteins in red color). Figure 4A also clearly demonstrates that some of the proteins 
have more interactions within the network than the others. Proteins that have more than 
10 interactions are presented in Figure 4B. On top of the list are the hub proteins for each 
cluster: TNF with 23 interactions (blue), PPARG with 21 interactions (green), and CCR7 
with 19 interactions (red). 
3.2.4. Transcription Factors 
We also aimed to elucidate which transcription factors could have their activity mod-
ulated by polyphenols and be involved in the regulation of the expression of genes ex-
tracted from the literature. Using the bioinformatic tool Enrichr to access the database 
TRRUST Transcription Factors 2019, we identified N = 37 transcription factors that are 
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significantly associated with our set of mRNAs (adjusted p-value < 0.05). The top 5 tran-
scription factors retrieved with this analysis include: RELA and NFKB1 with more than 
15 hits each, STAT1 with 9 hits, SPI1 and CEBPD (Figure 5A). Interconnections between 
predicted transcription factors and polyphenol modulated genes extracted from the liter-
ature are depicted in Figure 5B. 
 
A
Sym bol Nam e Num ber of interactions
TN F Tumor necrosis factor 23
PP ARG Peroxisome proliferator-activated receptor gamma 21
CCR7 C-C chemokine receptor type 7 19
CCL20 C-C motif chemokine 20 18
CXCL10 C-X-C motif chemokine 10 18
IL6 Interleukin-6 18
CXCL9 C-X-C motif chemokine 9 17
CCR5 C-C chemokine receptor type 5 17
CXCR3 C-X-C chemokine receptor type 3 16
MED1 Mediator of RNA polymerase II transcription subunit 1 16
CXCR1 C-X-C chemokine receptor type 1 15
CXCR2 C-X-C chemokine receptor type 2 15
CX3CR1 CX3C chemokine receptor 1 15
CD36 Platelet glycoprotein 4 15
CCL3 C-C motif chemokine 3 14
CCR1 C-C chemokine receptor type 1 14
CXCR6 C-X-C chemokine receptor type 6 14
STAT1 Signal transducer and activator of transcription 1-alpha/beta 13
CXCL6 C-X-C motif chemokine 6 13
MED17 Mediator of RNA polymerase II transcription subunit 17 12
MED14 Mediator of RNA polymerase II transcription subunit 14 12
MED23 Mediator of RNA polymerase II transcription subunit 23 12
IL1B Interleukin-1 beta 12
MED15 Mediator of RNA polymerase II transcription subunit 15 12
CXCL16 C-X-C motif chemokine 16 12
MED18 Mediator of RNA polymerase II transcription subunit 18 12
MED4 Mediator of RNA polymerase II transcription subunit 4 12
CCNC Cyclin-C 12
MED6 Mediator of RNA polymerase II transcription subunit 6 12
MED13 Mediator of RNA polymerase II transcription subunit 13 12
MED12 Mediator of RNA polymerase II transcription subunit 12 12
CCL22 C-C motif chemokine 22 11
B
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Figure 4. (A) Protein-protein interactions for proteins encoded by the extracted genes, as well as 
several neighboring proteins (up to 10 interactions within the first shell; up to 5 interactions within 
the second shell), organized in 3 clusters. (B) Proteins that have more than 10 interactions within the 
protein-protein interactions network. Top 3 proteins belong to a different cluster each. 
 
Sym bol Nam e Num ber of hits
RELA Transcription factor p65 20
NFKB1 Nuclear factor NF-kappa-B p105 subunit 17
STAT1 Signal transducer and activator of transcription 1-alpha/beta 9
SPI1 Transcription factor PU.1 6
CEBPD CCAAT/enhancer-binding protein delta 4
JUN Transcription factor AP-1 7
REL Proto-oncogene c-Rel 4
KLF2 Krueppel-like factor 2 3
PPARA Peroxisome proliferator-activated receptor alpha 4
E2F1 Transcription factor E2F1 5
SP1 Transcription factor Sp1 8
JUND Transcription factor jun-D 3
TRERF1 Transcriptional-regulating factor 1 2
NR3C2 Mineralocorticoid receptor 2
SIRT1 NAD-dependent protein deacetylase sirtuin-1 3
STAT2 Signal transducer and activator of transcription 2 2
KLF5 Krueppel-like factor 5 2
CEBPB CCAAT/enhancer-binding protein beta 3
STAT3 Signal transducer and activator of transcription 3 4
IRF3 Interferon regulatory factor 3 2
ATF3 Cyclic AMP-dependent transcription factor ATF-3 2
XBP1 X-box-binding protein 1 2
GATA2 Endothelial transcription factor GATA-2 2
NFKBIA NF-kappa-B inhibitor alpha 2
NR1H4 Bile acid receptor 2
SREBF2 Sterol regulatory element-binding protein 2 2
HIF1A Hypoxia-inducible factor 1-alpha 3
AHR Aryl hydrocarbon receptor 2
EGR1 Early growth response protein 1 3
FOXO1 Forkhead box protein O1 2
SREBF1 Sterol regulatory element-binding protein 1 2
RUNX3 Runt-related transcription factor 3 2
HSF1 Heat shock factor protein 1 2
ATF2 Cyclic AMP-dependent transcription factor ATF-2 2
STAT6 Signal transducer and activator of transcription 6 2
KLF4 Krueppel-like factor 4 2
RUNX1 Runt-related transcription factor 1 2
A
B
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Figure 5. Regulation of differentially expressed mRNAs at the transcriptional level. (A) Predicted 
transcription factors that regulate polyphenol modulated genes, arranged according to their p-val-
ues, in ascending order. (B) Interconnections between predicted transcription factors (in purple 
color) and polyphenol modulated genes (in yellow color). 
3.3. miRNAs—Bioinformatic Analyses 
3.3.1. miRNA Targets 
Whilst analyzing the eligible papers for data extraction, we identified N = 5 miRNAs 
which expression was modulated by polyphenols (Table 1). To elucidate their biological 
functions, we first aimed to retrieve their target mRNAs. To this aim, for each miRNA, 
their targets were mapped in 3 databases (TargetMiner, TargetScanVert, and miRDB), 
which were accessed through miRBase. For each miRNA, the targets that were in common 
for all 3 databases were considered for further analyses, such as pathways enrichment 
analyses and integration analyses. Using this approach, we obtained: hsa-miR-21-5p:74 
targets; hsa-miR-181b-5p:49 targets; hsa-miR-663a:81 targets; hsa-miR-30c-2-3p:290 tar-
gets; hsa-miR-34a-5p:278 targets. Interactions between miRNAs and their predicted target 
mRNAs are presented in Figure 6. 
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Figure 6. miRNAs modulated by polyphenols (red circles), their target mRNAs (blue circles), and interactions. 
3.3.2. Pathways Analyses of miRNA Targets 
We also conducted bioinformatic analysis of pathways that are significantly associ-
ated with the predicted miRNA targets. To this aim, targets of all 5 miRNAs were taken 
together, and duplicates were removed. In that way, 720 targets were identified and ana-
lyzed with GeneTrail2 for KEGG and BioCarta pathways. We identified in total N = 86 
KEGG and N = 21 BioCarta pathways that are significantly associated with miRNA targets 
(adjusted p-value < 0.05). Some of these pathways are associated with cellular processes, 
whereas others are related to various diseases. A deeper insight into the top 60 pathways 
associated with cellular processes (Figure 7) demonstrated that the vast majority is in-
volved in cell signaling, such as: MAPK signaling pathway (N = 28 hits: CACNA1E, 
CACNA2D2, CACNB1, CACNB2, DUSP8, ELK1, HSPA1B, JUND, KRAS, MAP2K1, 
MAP4K1, MEF2C, MKNK2, NTF3, PAK1, PDGFRA, PPM1A, PPP3R1, PPP5C, PRKACB, 
RASA1, RPS6KA3, RPS6KA4, RPS6KA5, RRAS, STK4, TAOK1, TGFB1), Wnt signaling 
pathway (N = 16 hits: CAMK2A, CCND1, CHD8, CTBP1, DAAM1, FZD4, FZD7, LEF1, 
NKD1, PPP3R1, PRKACB, PSEN1, ROCK2, SMAD4, TBL1XR1, WNT1), Ras signaling path-
way (N = 16 hits: EFNA1, ELK1, KITLG, KRAS, MAP2K1, MET, PAK1, PDGFRA, PIK3R1, 
PLCG1, PRKACB, RAB5B, RALGDS, RASA1, RRAS, STK4), or PI3K-Akt signaling pathway 
(N = 17 hits: BCL2, CCND1, CCNE2, CDK6, CREB3L1, EFNA1, KITLG, KRAS, MAP2K1, 
MET, PDGFRA, PHLPP2, PIK3R1, PPP2R3A, PPP2R5C, RELN, YWHAQ). 
Some of the pathways are involved in the regulation of endothelial function, such as: 
regulation of actin cytoskeleton (N = 14 hits: ARPC2, CYFIP2, IQGAP3, KRAS, MAP2K1, 
MYH9, PAK1, PDGFRA, PIK3R1, PIP5K1A, ROCK1, ROCK2, RRAS, VCL), focal adhesion 
(N = 12 hits: BCL2, CCND1, ELK1, MAP2K1, MET, PAK1, PDGFRA, PIK3R1, RELN, 
ROCK1, ROCK2, VCL), cell adhesion molecules (N = 9 hits: CD34, CDH4, CNTN2, CNT-
NAP1, CNTNAP2, MPZ, NEGR1, NFASC, NRXN2), gap junction (N = 8 hits: GUCY1A2, 
HTR2C, ITPR2, KRAS, MAP2K1, PDGFRA, PRKACB, PRKG2), or adherens junction (N = 7 
hits: CTNND1, LEF1, MET, SMAD2, SMAD4, SSX2IP, VCL). Interestingly, some of the top 
pathways are also related to the function of the nervous system such as: axon guidance 
(N = 13 hits: EFNA1, EPHA4, EPHB2, KRAS, MET, PAK1, PLXNA2, PPP3R1, RASA1, 
ROBO2, ROCK1, ROCK2, SEMA4G), or glutamatergic synapse (N = 13 hits: GLUL, 
GNAO1, GRIN2D, GRIN3A, GRM4, GRM7, HOMER1, ITPR2, PPP3R1, PRKACB, 
SHANK2, SLC17A7, SLC1A2). 
 




Figure 7. Top 60 KEGG and BioCarta pathways related to cellular processes, significantly associated with predicted miRNA targets (x-axis represents the number of hits; within each 
group, pathways are arranged according to their p-values, in ascending order). KEGG pathways are marked with *; BioCarta pathways are marked with **. 
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3.4. Integration Analyses 
3.4.1. Integration of mRNAs and miRNA Targets 
Comparative analysis of mRNAs extracted from the literature and the predicted 
miRNA targets was conducted using the bioinformatic tool Metascape. This analysis 
demonstrated that within these two gene sets, there are only three genes that overlap, 
namely FASN, ADIPOR2, and OLR1 (presented with purple curves in Figure 8A). Despite 
the small number of overlapping genes, however, this analysis retrieved a remarkable 
number of functional interactions between these two gene sets, demonstrated with a num-
ber of genes that share the same enriched term (blue curves in Figure 8A). Detailed infor-
mation about the genes from both gene sets that belong to the top 20 enriched terms is 
presented in Table S1 in the Supplementary Materials. Although there are terms that are 
enriched exclusively for one of the analyzed gene sets, such as regulation of lipid locali-
zation, cellular response to lipopolysaccharide or cytokine-mediated signaling pathway 
for mRNAs, or signaling by TGF-beta family members for miRNA targets, the heatmap of 
enriched terms demonstrates that these two gene sets share several important gene ontol-
ogies, including regulation of cell adhesion or signal release (Figure 8B). 
 
Figure 8. Comparative analysis of mRNAs extracted from the literature and the predicted miRNA targets. (A) Overlapping 
genes (purple curves) and genes that share the same enriched term (blue curves). (B) Heatmap of enriched terms, colored 
by p-values. 
3.4.2. Integration of mRNA and miRNA-Target Pathways 
The global network of enriched pathway interactions of our study categories 
(mRNAs and miRNA targets) was grouped and shown in Figure 9A, where individual 
clusters were not differentiated, but rather a centralized network. The pathways with the 
highest degree of connections with other pathways into the network include MAPK sig-
naling pathway, thyroid hormone signaling pathway, TNF signaling pathway, estrogen 
signaling pathway, Rap1 signaling pathway, and gap junction. From this integration anal-
ysis, we identified common enriched pathways to mRNAs and miRNA targets that in-
clude MAPK signaling pathway, thyroid hormone signaling pathway, TNF signaling 
pathway, PI3K-Akt signaling pathway, T cell receptor signaling pathway, focal adhesion, 
regulation of actin cytoskeleton, cell adhesion molecules (CAMs), PPAR signaling path-
way. Regarding PPAR signaling pathway, it has been identified as significantly over-rep-
resented with 5 differentially expressed genes (CD36, OLR1, PPARA, PPARD, PPARG) but 
also with 6 genes (ACSL1, ACSL4, CYP8B1, OLR1, SCD, SLC27A4) that are targets of miR-
NAs. Among these genes, OLR1 was identified both as differentially expressed and target 
A B
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of hsa-miR-21-5p, suggesting the polyphenols by modulating expression of this miRNA 
can affect level of mRNA of OLR1 (Figure 9B). This integrated analysis of differentially 
expressed genes identified using targeted approach across different studies shows com-
plex and multi-gene mode of action of polyphenols, including both protein coding and 
non-coding genes involved in pathways that form a complex network that allow regula-
tion of cellular functions. 
 
Figure 9. (A) mRNAs and miRNA-targets network of pathways. List of differentially expressed genes and miRNA targets 
were used to perform a global GeneTrail2 enrichment analysis and identify enriched pathways. A pathway-connections 
network was built in Cytoscape. Node colored labels represent the categories (mRNA, miRNA targets or combination) 
from which the pathways were enriched. Red circles are miRNA pathways, yellow are miRNA and mRNA pathways, 
green are mRNA pathways. (B) PPAR signaling pathway in 2 levels, one for mRNA and one for miRNA targets. 
3.4.3. mRNAs, miRNAs and Transcription Factors Integration Analysis 
To visualize interactions between polyphenol modulated genes (N = 58) and miRNAs 
(N = 5), as well as the predicted transcription factors (N = 37) that regulate the expression 
of polyphenol modulated genes, we used the bioinformatic tool OmicsNet. PPIs of pro-
teins that are coded by polyphenol modulated genes are retrieved using the STRING da-




























Figure 10. 3D-layer presentation of interactions of proteins that are coded by polyphenol modulated 
genes (in red color), polyphenol modulated miRNAs (in blue color), and the predicted transcription 
factors (in green color). 
Transcription factors, retrieved using the TRRUST database, are presented above the 
PPIs, in green color. Modulated miRNAs by polyphenols are presented in blue color. Fig-
ure 10 clearly depicts the presence of numerous but specific interactions between these 
molecules, as determinants of the positive effects of polyphenols on cardiometabolic 
health in humans. 
This study presents several limitations. We only used genomic data available from 
studies that used targeted gene expression analysis. There are several studies that have 
used untargeted genomic analysis, and provide significant information on genomic mod-
ifications by plant food bioactives. However, because of the large difference in number of 
differentially expressed genes identified due to approaches used, we did not include stud-
ies which used untargeted approaches. Moreover, this systematic analysis only included 
studies with positive effects on cardiometabolic endpoint analysis, however there are also 
studies that reported changes in the expression of specific genes related to other health 
effects. 
4. Discussion 
Cardiometabolic disorders are among the leading causes of mortality in human pop-
ulation and therefore attract much interest for finding effective solutions for prevention 
and treatment. Since diet and lifestyle are important factors influencing the onset and pro-
gression of cardiometabolic disorders, preventive measures are largely directed towards 
their modification. In terms of diet, polyphenols have an important role as plant food bi-
oactives with protective effects. Namely, numerous epidemiological and human interven-
tion studies indicate that polyphenols generally have positive effects on human cardi-
ometabolic health [9,12]. Moreover, recent studies highlight the importance of interindi-
vidual variability in response to polyphenols intake, which is determined by many factors, 
Predicted 
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including genetic variability. However, molecular mechanisms underlying health-pro-
moting effects of polyphenols are not entirely clear, which is even more apparent for the 
potential influence of specific gene variants in humans. Aiming to clarify at least some of 
the molecular mechanisms that underlie the beneficial effects of polyphenols on cardi-
ometabolic health, we conducted a systematic literature search followed by comprehen-
sive bioinformatic analyses. The availability of data for significant modulation of both 
mRNAs and miRNAs allowed us to make an mRNA-miRNA integration, as well as inte-
gration at an additional, third level, analyzing the predicted transcription factors that reg-
ulate polyphenol modulated mRNAs. 
Bioinformatic analyses of polyphenol modulated mRNAs demonstrated that these 
genes are mainly involved in processes such as inflammation, lipid metabolism and en-
dothelial function. Network analyses pinpointed several genes with central positions 
within the functional clusters and the highest number of interactions, such as TNF, NFK-
BIA, PPARG, and CCR7. Among transcription factors, the most prominent role is demon-
strated for RELA/NFKB1, STAT1, and JUN, but SIRT1, or KLF4 are also significantly as-
sociated. Most of these genes and molecules are important mediators of inflammatory re-
sponse, which is the major underlying mechanism of cardiometabolic disorders [59]. In-
deed, low-grade chronic inflammation, also referred to as metaflammation, has been iden-
tified as causative for obesity-induced insulin resistance [60], further progressing to ath-
erogenic dyslipidemia, metabolic syndrome, type 2 diabetes and/or metabolic associated 
fatty liver disease (MAFLD) [61,62]. The process is initiated when obese, hypertrophied 
and dysfunctional adipocytes increase the secretion of free fatty acids and pro-inflamma-
tory cytokines and activate adipose tissue-resident macrophages into pro-inflammatory 
M1 phenotype. M1 macrophages additionally release a variety of pro-inflammatory cyto-
kines, including TNFα, IL1β and IL6, which act on adipocytes, liver and skeletal muscles, 
causing local and systemic insulin resistance, and oxidative stress [63,64]. The effects of 
these pro-inflammatory stimuli on insulin signaling are mediated through several inflam-
mation-related kinases, including IKK and JNK. In addition to activation of NF-kappa B 
and AP1 respectively, leading to transcriptional activation of pro-inflammatory cytokines, 
these kinases are also involved in inhibitory serine phosphorylation of IRS, which results 
in inactivation of the PI3K-Akt pathway, impaired insulin signaling and insulin resistance 
[65]. This observation can be corroborated with studies that revealed the capacity of pol-
yphenols to negatively regulate the NF-kappa B signaling pathway, depress the phos-
phorylation of kinases, inhibit NF-kappa B translocation into the nucleus but also interfere 
interactions between NF-kappa B and DNA [66]. It has also been shown, using NF-kappa 
B reporter gene assays, that monomeric and oligomeric flavanols from grape seeds can 
decrease the activity of this transcription factor [67]. The modulation of activity of tran-
scription factors by polyphenols is probably mediated through interaction of these bioac-
tives with cell signaling proteins. For example, we have previously shown that anthocya-
nins present high potential binding with cell signaling proteins like mTOR, FAK1, 
Smad2/3, MAPKs as JNK1/2/3 or MAP2K1 as well as IκB proteins [24]. These cell signaling 
proteins regulate the activity of transcription factors such as STAT1, JUN, SIRT1, NF-
kappa B, or SPI1. Similar observation has been reported for epicatechin metabolites [68]. 
These results corroborate with other studies which showed that polyphenols can modify 
phosphorylation and activity of these cell signaling proteins and transcription factors 
[69,70]. Therefore, by interacting with cell signaling proteins, polyphenols will modulate 
their kinase activity, which in turn will affect activation of transcription factors and con-
sequently expression of genes. Importantly, our bioinformatic analyses identified the NF-
kappa B signaling pathway, along with adipocytokine signaling pathway, TNF signaling 
pathway, Toll-like receptor signaling pathway, and PI3K-Akt signaling pathway among 
the most significantly modulated by dietary polyphenols, demonstrating their anti-in-
flammatory and insulin-sensitizing mode of action. 
Nutrients 2021, 13, 2326 23 of 29 
 
 
The activity of NF-kappa B is also modulated by SIRT1, an NAD+ dependent deacety-
lase, which was identified in our bioinformatic analysis among the TFs significantly in-
volved in the regulation of polyphenol modulated genes. In particular, SIRT1 has the abil-
ity to deacetylate the p65 subunit of NF-kappa B, thus inhibiting its transcriptional activity 
[71], which results in reduced inflammation in adipocytes and macrophages [72,73]. SIRT1 
also deacetylates AP-1, and represses IKK- and JNK-related pathways, which further con-
tributes to its cardiometabolic health promoting properties [74]. In addition, SIRT1 con-
tributes to the amelioration of oxidative stress via modulation of transcriptional activity 
of PGC-1α, FOXO3a, and NRF2, resulting in the upregulation of antioxidant enzymes 
[75,76]. The beneficial effects of SIRT1 in the vasculature protect against atherosclerosis. 
The main mechanisms include: improvement of endothelial function through activation 
of eNOS, decreased expression of endothelial adhesion molecules and endothelial tissue 
factor through deacetylation of p65 subunit of NF-kappa B, and decreased oxidative stress 
through induction of antioxidant enzymes. In addition, SIRT1 promotes deacetylation of 
p65 subunit of NF-kappa B in macrophages from the sub-endothelium, leading to repres-
sion of LOX-1, a scavenging receptor for oxLDL, and prevention of foam cell formation 
[77]. It is of note that we identified LOX-1 (OLR1 is the official gene name) as significantly 
modulated by polyphenols within both mRNAs extracted from the literature and pre-
dicted miRNA targets retrieved with our bioinformatic analyses, which strongly indicates 
its importance in the atheroprotective effects of polyphenols. Besides resveratrol that has 
been extensively studied as a SIRT1 activator, other SIRT1 activators and NAD+ boosting 
compounds also demonstrate promising effects on cardiometabolic health [78]. 
In addition to their ability to modulate the expression of protein-coding genes, poly-
phenols are also capable of modulating miRNA expression, which has also been demon-
strated in our systematic literature search. Namely, we have identified miRNAs that are 
involved in inflammation associated with cardiometabolic disorders as significantly mod-
ulated with polyphenol intervention. For example, it has been demonstrated that grape 
polyphenols enriched with resveratrol significantly upregulate miR-21 and miR-181b in 
PBMCs of diabetic men with hypertension and coronary artery disease, which was accom-
panied with beneficial cardiometabolic outcomes (Table 1). These results are in line with 
the data from human studies that report decreased miR-21 in PBMCs in obesity, which is 
inversely correlated with TNFα and IL6 secreted by PBMCs [79], as well as decreased 
plasma miR-21 in hypertensive subjects [80]. Mechanisms underlying the beneficial effects 
of miR-21 on cardiometabolic health have been explored in both in vitro and animal mod-
els. More specifically, it has been demonstrated that over-expression of miR-21 in insulin-
resistant adipocytes significantly increases the insulin-stimulated glucose uptake via 
modulation of PTEN-AKT pathway [81], whereas its over-expression in livers of diabetic 
mice suppresses hepatic gluconeogenesis and improves glucose tolerance [82]. The data 
for miR-21 are in concordance with the data that are available for miR-181b. For example, 
miR-181b is significantly decreased in livers and plasma of diabetic mice [83], and in aor-
tas of older mice [84], whereas in patients with poorly controlled type 2 diabetes, plasma 
miR-181b negatively correlates with the indicators of pro-coagulant and pro-inflamma-
tory state [85]. 
Opposite to miR-21 and miR-181b, the upregulation of miR-34a is associated with 
impaired cardiometabolic health. For example, it has been reported that circulating miR-
34a is increased in hypertensive subjects [80], as well as in obese children with non-alco-
holic fatty liver disease (NAFLD) and/or insulin resistance [86]. Moreover, miR-34a is up-
regulated in PBMCs from patients with type 2 diabetes [87], and in atherosclerotic plaques 
in humans and apoE deficient mice [88]. In atherosclerosis, a central role has been ascribed 
to macrophage miR-34a, as a key regulator of macrophage cholesterol homeostasis and 
inflammation [88]. Some of the mechanisms underlying the detrimental effects of miR-34a 
on cardiometabolic health have also been demonstrated in inflamed and dysfunctional 
adipose tissue in obesity. Indeed, in addition to the progressive increase of miR-34a in 
mouse epididymal white adipose tissue upon administration of high-fat diet, it has also 
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been demonstrated that in obesity the hypertrophic adipocytes’ exosomal miR-34a sup-
presses the IL4-induced polarization of macrophages into anti-inflammatory M2 pheno-
type, by targeting the transcription factor KLF4 [89]. Importantly, KLF4 is among the tran-
scription factors that are identified with our bioinformatic analysis as significantly associ-
ated with polyphenol modulated genes (Figure 5A). Accordingly, there is experimental 
evidence that pre-treatment with olive oil polyphenol hydroxytyrosol prevents TNFα-in-
duced upregulation of miR-34a in cultured human adipocytes and adipocyte-derived ex-
osomes, with concomitant prevention of inflammation and oxidative stress [90]. 
Bioinformatic analyses demonstrated that identified miRNA targets play a role in 
different cellular functions and cell signaling. Among the pathways identified are those 
regulating actin cytoskeleton, focal adhesion, adherens, and gap junction, actin organiza-
tion and cell adhesions. The adhesion of immune cells to vascular endothelium and their 
trans-endothelial migration are controlled by the combined action of these pathways. The 
permeability-regulating factors act through small GTPases that regulate the architecture 
of the cytoskeleton, which impacts the morphology of the cell and cell–cell junctions and 
facilitates cell transmigration [91]. Proatherogenic stimuli such as diabetes, dyslipidemia, 
and oxidative stress initiate impairment of endothelial function resulting in vascular dys-
function that leads to development of atherosclerotic disease, the initial step for multiple 
cardiovascular disorders. Proinflammatory stimuli cause significant disruption of the en-
dothelial barrier and increased junctional permeability which facilitates trans-endothelial 
migration of immune cells to the arterial intima and induction of vascular inflammation 
[92]. Our analysis suggests that polyphenols, by regulating expression of miRNAs target-
ing genes in these pathways, can prevent or diminish transmigration of immune cells and 
consequently the development of vascular dysfunction. This observation can be corrobo-
rated with a few studies which showed that exposure of endothelial cells to flavanol me-
tabolites decreases adhesion and transmigration of immune cells [67,68]. Moreover, sev-
eral pathways related to neuronal function have been identified, such as axon guidance 
or glutamatergic synapse. It has been shown that genes that are expressed in neuronal 
cells could also be expressed in other type of cells. For example, PPP2R3A, expressed also 
in blood cells, was found to promote activation of NF-kappa B via coupling to Gα12/13, 
the small GTPase protein RhoA and RhoA-activated kinase, mechanism which increases 
expression of adhesion molecules and inflammatory mediators [93]. Other genes, such as 
GLUL, SLC1A2, HOMER1, or GRIN2D were observed to be expressed in immune cells 
(from GEO database (https://www.ncbi.nlm.nih.gov/geoprofiles, accessed on 5 November 
2020)). Expression of some of these genes has been observed to be affected in patients with 
neurological disorders. For example, HOMER1 gene was observed to be expressed in pa-
tients with Alzheimer’s diseases (https://www.ncbi.nlm.nih.gov/geoprofiles/35623805, ac-
cessed on 5 November 2020), suggesting that polyphenols could also affect neurological 
disorders. Indeed, it has been suggested that polyphenol consumption could be involved 
in prevention of neurodegenerative disorders and improvement of cognitive function 
[94,95]. 
5. Conclusions 
In summary, this systematic literature search and the subsequent integrative bioin-
formatic analyses allowed us to add new value to the existing data. Applied bioinformatic 
methods transformed the list of polyphenols modulated genes into valuable sources of 
information for a better understanding of some of the molecular mechanisms of action of 
polyphenols, but also toward the identification of potential target genes for future nutri-
genetic studies. 
Supplementary Materials: The following are available online at www.mdpi.com/2072-
6643/13/7/2326/s1, Table S1. Integration of mRNAs and miRNA Targets: Genes from both gene sets 
that belong to the top 20 enriched terms identified using the bioinformatic tool Metascape. 
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